SynthesisMedicine2018
The CDK4/6 inhibitor in HR-positive advanced breast cancer: A systematic review and meta-analysis.
Wu Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it
SynthesisMedicine2018
Wu Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.